Efficacy and safety of Hydroxychloroquine in the Treatment of Type II Diabetes Mellitus: A Double Blind, Randomized Comparison with Pioglitazone.
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2012
At a glance
- Drugs Hydroxychloroquine (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Ipca Laboratories
- 09 May 2012 Actual initiation date 28 Apr 2010 added as reported by Clinical Trials Registry - India.
- 08 Feb 2010 New trial record